Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Diseases (Basel, Switzerland)|May 24, 2024
Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic OptionBenedetta Tirone, Gerardo Cazzato, Francesca Ambrogio, et al.
Diagnostics (Basel, Switzerland)|March 13, 2025
Can Dermoscopy Be a Useful Follow-Up Tool in Patients with Discoid Lupus Treated with Anifrolumab?Francesca Ambrogio, Caterina Foti, Silvia Noviello, et al.
Journal of Clinical Medicine|February 26, 2025
Successful Treatment of MEK Inhibitor-Induced Paronychia in Neurofibromatosis with Photodynamic Therapy: A Case Report and Review of the Therapeutic OptionsFrancesca Ambrogio, Teresa Perillo, Domenico Bonamonte, et al.
Journal of Functional Morphology and Kinesiology|July 24, 2026
Performance of Handwriting and Digital Typing After Carpal Tunnel Release: The TACTUS (Typing Ability in Carpal Tunnel Syndrome) StudyLorenzo Alirio Diaz Balzani, Guglielmo Torre, Erika Albo, et al.
Dermatology Reports|April 28, 2026
Morbihan disease in an Asian patient: diagnostic and therapeutic challengesGiulia Ciccarese, Riccardo Bortone, Alexandre Raphael Meduri, et al.
Bioengineering (Basel, Switzerland)|October 25, 2024
Targeted Drug Delivery in Periorbital Non-Melanocytic Skin MalignanciesBenedetta Tirone, Anna Scarabosio, Pier Luigi Surico, et al.
Frontiers in Immunology|October 13, 2025
Case Report: Occupational bullous dermatosis: first report of skin lesions induced by PVC welding fume in a manufacturing workerAngela Stufano, Piero Lovreglio, Gerardo Cazzato, et al.
Diagnostics (Basel, Switzerland)|February 26, 2025
Response Rate to the Intervention with Tirbanibulin 1% Ointment for Treating Actinic Keratoses in People Living with HIV InfectionGiulia Ciccarese, Francesco Drago, Lucia Lospalluti, et al.
Archives of Dermatological Research|May 23, 2025
Efficacy and safety of JAK inhibitors in patients aged > 60 years with moderate-to-severe atopic dermatitis: a 52-week multicenter, real-life study-IL AD (Italian Landscape Atopic Dermatitis)Luca Potestio, Cataldo Patruno, Alessandra Narcisi, et al.
Acta Dermato-Venereologica|April 15, 2026
Efficacy and Safety of Abrocitinib for Moderate-to-severe Atopic Dermatitis in Adults: A 52-week Real-world Multicentre StudyIL-AD (Italian Landscape Atopic Dermatitis)Elena Pezzolo, Rossi Mariateresa, Raul Armando Luyo Saboya, et al.
Pageof 2